SSKN icon

Strata Skin Sciences

2.89 USD
-0.16
5.25%
At close Dec 20, 4:00 PM EST
1 day
-5.25%
5 days
-4.93%
1 month
-6.47%
3 months
-4.62%
6 months
-9.69%
Year to date
-44.42%
1 year
-54.70%
5 years
-86.86%
10 years
-95.48%
 

About: Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Employees: 99

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

12% more funds holding

Funds holding: 17 [Q2] → 19 (+2) [Q3]

10.38% less ownership

Funds ownership: 39.33% [Q2] → 28.95% (-10.38%) [Q3]

22% less capital invested

Capital invested by funds: $4.24M [Q2] → $3.32M (-$918K) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for SSKN.

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
HORSHAM, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and Chief Executive Officer Dr. Dolev Rafaeli will participate in the Benchmark Company 13th Annual Discovery Investor Conference that is being held on Wednesday, December 11, 2024, at the New York Athletic Club in New York City.
STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
Neutral
Seeking Alpha
1 month ago
STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript
STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript
STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
HORSHAM, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended September 30, 2024 and provides a corporate update.
STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Neutral
GlobeNewsWire
1 month ago
STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group
HORSHAM, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that the United States District Court for the Eastern District of Pennsylvania entered a court order in favor of the Company in its complaint against LaserOptek America Corp. (“LaserOptek”), Monarch Aesthetic Services, Inc. d/b/a Monarch Laser Services (“MLS”), and The Pinnacle Health Group (“Pinnacle”), collectively referred to as the “Defendants.”
STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group
Neutral
GlobeNewsWire
1 month ago
STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update
HORSHAM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report third quarter 2024 financial results on Wednesday, November 13, 2024 after the market close.
STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update
Neutral
GlobeNewsWire
2 months ago
STRATA Skin Sciences' XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference
HORSHAM, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that JMEC Co., Ltd., its longstanding Japanese strategic partner and distributor, sponsored a seminar with two lectures on XTRAC® excimer devices on Saturday, October 12, 2024, at the 75th Annual Meeting of the Chubu Branch of the Japanese Dermatological Association held in Nagoya, Japan. Professor Kazutoshi Harada of Tokyo Medical University chaired the seminar.
STRATA Skin Sciences' XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference
Neutral
GlobeNewsWire
2 months ago
STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit with Maxim Director of Research and Senior Healthcare Analyst Anthony Vendetti. The conference is being held virtually on October 15 – 17, 2024.
STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Neutral
GlobeNewsWire
3 months ago
STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024
HORSHAM, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will present a corporate overview at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024. The conference is being held virtually from September 24 – 25, 2024.
STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024
Positive
Zacks Investment Research
3 months ago
Despite Fast-paced Momentum, Strata Skin Sciences (SSKN) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Strata Skin Sciences (SSKN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Strata Skin Sciences (SSKN) Is Still a Bargain Stock
Neutral
GlobeNewsWire
3 months ago
STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference
HORSHAM, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on Thursday, September 12, 2024, at the Yale Club in Midtown Manhattan, New York City.
STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference
Charts implemented using Lightweight Charts™